Search Results - Varnell, Tracey

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Mometasone furoate (MF) improves lung function in pediatric asthma: A double‐blind, randomized controlled dose‐ranging trial of MF metered‐dose inhaler

    Mometasone furoate (MF) improves lung function in pediatric asthma: A double‐blind, randomized controlled dose‐ranging trial of MF metered‐dose inhaler by Amar, Niran J., Shekar, Tulin, Varnell, Tracey A., Mehta, Anish, Philip, George

    Published in Pediatric pulmonology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Quantitative measurement of cysteinyl leukotrienes and leukotriene B 4 in human sputum using ultra high pressure liquid chromatography–tandem mass spectrometry

    Quantitative measurement of cysteinyl leukotrienes and leukotriene B 4 in human sputum using ultra high pressure liquid chromatography–tandem mass spectrometry by Chappell, Gloria Paola, Xiao, Xiaoyao, Pica-Mendez, Arnaldo, Varnell, Tracey, Green, Stuart, Tanaka, Wesley K., Laterza, Omar

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A phase 3 study evaluating the safety and efficacy of a pediatric dose of mometasone furoate with and without formoterol for persistent asthma

    A phase 3 study evaluating the safety and efficacy of a pediatric dose of mometasone furoate with and without formoterol for persistent asthma by Weinstein, Cindy L. J., Gates, Davis, Zhang, Xiaoli, Varnell, Tracey, Mok, Wilson, Vermeulen, Jan H., Amar, Niran J., Jain, Neal

    Published in Pediatric pulmonology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Mometasone Furoate (MF) Improves Lung Function in Pediatric Asthma: A Dose-Ranging Study of MF Metered-Dose Inhaler (MDI)

    Mometasone Furoate (MF) Improves Lung Function in Pediatric Asthma: A Dose-Ranging Study of MF Metered-Dose Inhaler (MDI) by Amar, Niran J., MD, FAAAAI, Shekar, Tulin, MS, Varnell, Tracey, Mehta, Anish, Philip, George, MD

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Quantitative measurement of cysteinyl leukotrienes and leukotriene B sub(4) in human sputum using ultra high pressure liquid chromatography-tandem mass spectrometry

    Quantitative measurement of cysteinyl leukotrienes and leukotriene B sub(4) in human sputum using ultra high pressure liquid chromatography-tandem mass spectrometry by Chappell, Gloria Paola, Xiao, Xiaoyao, Pica-Mendez, Arnaldo, Varnell, Tracey, Green, Stuart, Tanaka, Wesley K, Laterza, Omar

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Quantitative measurement of cysteinyl leukotrienes and leukotriene B₄ in human sputum using ultra high pressure liquid chromatography–tandem mass spectrometry

    Quantitative measurement of cysteinyl leukotrienes and leukotriene B₄ in human sputum using ultra high pressure liquid chromatography–tandem mass spectrometry by Chappell, Gloria Paola, Xiao, Xiaoyao, Pica-Mendez, Arnaldo, Varnell, Tracey, Green, Stuart, Tanaka, Wesley K, Laterza, Omar

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2

    Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2 by Tilley, Jefferson W, Chen, Li, Fry, David C, Emerson, S. Donald, Powers, Gordon D, Biondi, Denise, Varnell, Tracey, Trilles, Richard, Guthrie, Robert, Mennona, Francis, Kaplan, Gerry, LeMahieu, Ronald A, Carson, Mathew, Han, Ru-Jen, Liu, C.-M, Palermo, Robert, Ju, Grace

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity

    Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity by Greenfeder, S A, Varnell, T, Powers, G, Lombard-Gillooly, K, Shuster, D, McIntyre, K W, Ryan, D E, Levin, W, Madison, V, Ju, G

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Structure-function analysis of human IL-1α : identification of residues required for binding to the human type I IL-1 receptor

    Structure-function analysis of human IL-1α : identification of residues required for binding to the human type I IL-1 receptor by LABRIOLA-TOMPKINS, E, CHITRA CHANDRAN, VARNELL, T. A, MADISON, V. S, JU, G

    Published in Protein engineering
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    Insertion of a Structural Domain of Interleukin (IL)-1β Confers Agonist Activity to the IL-1 Receptor Antagonist

    Insertion of a Structural Domain of Interleukin (IL)-1β Confers Agonist Activity to the IL-1 Receptor Antagonist by Scott A. Greenfeder, Tracey Varnell, Gordon Powers, Kathleen Lombard-Gillooly, David Shuster, Kim W. McIntyre, Dene E. Ryan, Wayne Levin, Vincent Madison, Grace Ju

    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Insertion of a Structural Domain of Interleukin (IL)-1β Confers Agonist Activity to the IL-1 Receptor Antagonist

    Insertion of a Structural Domain of Interleukin (IL)-1β Confers Agonist Activity to the IL-1 Receptor Antagonist by Greenfeder, Scott A., Varnell, Tracey, Powers, Gordon, Lombard-Gillooly, Kathleen, Shuster, David, McIntyre, Kim W., Ryan, Dene E., Levin, Wayne, Madison, Vincent, Ju, Grace

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: